Samuel P Sears Jr insider trades

Open-market stock purchases and sales by Samuel P Sears Jr, Director at Inhibitor Therapeutics, Inc, from SEC Form 4 filings since Oct 21, 2011.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • INTI Inhibitor Therapeutics, Inc: other filings, last Apr 1, 2025
  • BDSI Biodelivery Sciences International Inc: 9 sales, last Nov 15, 2017
  • HPPI HedgePath Pharmaceuticals, Inc: other filings, last Jul 1, 2016
  • CBTEQ Commonwealth Biotechnologies Inc: other filings, last Apr 12, 2013

Get free alerts when Samuel P Sears Jr files a new trade →